Fig. 1.
![Comparison of outcome for adult de novo AML patients with t(9; 11) and with other translocations involving band 11q23 [t(11q23)] at diagnosis. (A) Shows probability of remaining in CR, (B) shows probability of EFS, and (C) shows probability of survival for patients with t(9; 11) compared with those with t(11q23).](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/90/11/10.1182_blood.v90.11.4532/3/bl_0030f1c.jpeg?Expires=1720323997&Signature=xmMEvbOCEGJRk5IqtIGuindjVEnZzLsFI3WQF4gUbWgutg5yocquMzLnefuP5MMjFp5BGfIr8syjnXbZ5oVz6UGZtant~mGJ3NLKju2FgrC7RTNAbjbR-BR4kN27lNkHJ~nvF9wkhpsqfarwzO8IOd4PDf~tKMrExDSzIVqiBkScpSihlJhorZfU0htupZIHHdNHhtFHgrk1NIsbbcxSTiGFsMBUmDWpN6FCqi7OQ~Ife654ueZPUt3PZSgeVyLcFZ~r1lQCu2fd4Pi61F2mAVpFBPH~xam34qqzFbrnF3hHrK3wOr6gRd5tsvAb8iojQTa9cEWnx212U5Fthj~EhA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Comparison of outcome for adult de novo AML patients with t(9; 11) and with other translocations involving band 11q23 [t(11q23)] at diagnosis. (A) Shows probability of remaining in CR, (B) shows probability of EFS, and (C) shows probability of survival for patients with t(9; 11) compared with those with t(11q23).
